Herd immunity is a pipe dream. .
Officials with the Archdiocese of Galveston-Houston said that 100 percent of students who attend St. Theresa Catholic School are vaccinated against the illness. That said, those who have received the whooping cough vaccine can sometimes still contract the disease if they are exposed.
If this occurs, the symptoms are typically milder, however.
Whooping cough, or pertussis, is a very contagious disease that spreads through coughing or sneezing. It can take up to three weeks for symptoms to appear. Late-stage symptoms may include rapid coughing followed by a high-pitched “whoop” sound, vomiting and exhaustion. Parents should be on the lookout for sounds, symptoms of whooping cough.
Pertussis can be fatal in infants.
IT'S NOT THE FIRST TIME.
The last school outbreak in Houston was during 2015-2016, a health department spokesman said Wednesday. In that instance, there were no serious adverse outcomes and the school didn’t close.
The illness starts with such symptoms as a runny or stuffed-up nose, sneezing, mild cough and a pause in breathing, then develops into more severe coughing.
The archdiocese’s letter urges anyone in contact with St. Theresa students to contact their doctor if they exhibit the first symptoms.
The archdiocese letter said that all of St. Theresa’s students are vaccinated against the infection, also known as pertussis.
ONE DIDN'T WORK, THEY WENT FOR TWO, NOW SAY GET THREE?
WHY?
In 1986, public health officials stated that MMR vaccination rates for kindergarten children were in excess of 95 percent and that one dose of live attenuated measles, mumps and rubella vaccine (MMR) would eliminate the three common childhood diseases in the U.S.
But in 1989, parents were informed that a single dose of MMR vaccine was inadequate for providing lifelong protection against these common childhood diseases and that children would need to get a second dose of MMR.
MMR Also Does Not Work as Advertised
Today, 95 percent of children entering kindergarten have received two doses of MMR vaccine, as have 92 percent of school children ages 13 to 17 years.
According to a lawsuit filed eight years ago, the manufacturer of mumps vaccine — which is also the sole provider of MMR vaccine in the U.S. — is accused of going to illegal lengths to hide the vaccine’s ineffectiveness.
So, might this resurgence of mumps simply be the result of using a vaccine that doesn’t provide immunity to begin with? And, if so, why add more of something that doesn’t work? After all, the MMR vaccine is not without its risks
In some states, the MMR vaccination rate is approaching 100 percent. Despite achieving the sought-for MMR vaccination rate for more than three decades, which theoretically should ensure “herd immunity,” outbreaks of both measles and mumps keep occurring — and many of those who get sick are children and adults who have been vaccinated.
Both Science Magazine and The New York Times reported in 2018 that mumps is making a strong comeback among college students, with hundreds of outbreaks occurring on U.S. campuses over the past two decades.
During summer 2017, the Minnesota Department of Health reported its largest mumps outbreak since 2006.
According to recent research, the reason for this appears to be, at least in part, "waning vaccine-acquired immunity".
In other words, protection from the MMR vaccine is wearing off quicker than expected. Science Magazine wrote:
“[Epidemiologist Joseph Lewnard and immunologist Yonatan Grad, both at the Harvard T. H. Chan School of Public Health in Boston] compiled data from six previous studies of the vaccine’s effectiveness carried out in the United States and Europe between 1967 and 2008. (None of the studies is part of a current fraudulent claims lawsuit against U.S. vaccine maker Merck.)
Based on these data, they estimated that immunity to mumps lasts about 16 to 50 years, or about 27 years on average. That means as much as 25 percent of a vaccinated population can lose immunity within eight years, and half can lose it within 19 years … The team then built mathematical models using the same data to assess how declining immunity might affect the susceptibility of the U.S. population.
When they ran the models, their findings lined up with reality.
For instance, the model predicted that 10- to 19-year-olds who had received a single dose of the mumps vaccine at 12 months were more susceptible to infection; indeed, outbreaks in those age groups happened in the late 1980s and early 1990s. In 1989, the Centers for Disease Control and Prevention added a second dose of the vaccine at age 4 to 6 years. Outbreaks then shifted to the college age group.”
A Third Booster Shot May Be Added
According to public health officials, the proposed solution to boosting vaccine-acquired mumps immunity in the U.S. population is to add a third booster shot of MMR vaccine at age 18.
ONE DIDN'T WORK, TWO DIDN'T WORK, LET'S GO FOR THREE?
REALLY?
THE VACCINE INDUSTRY WILL NOT SEPARATE THE THREE VACCINES.
Unfortunately, adding a booster for mumps means giving an additional dose of measles and rubella vaccines as well, as the three are only available in the combined MMR vaccine or combined MMR-varicella (MMRV) vaccine. At present, a third MMR shot is routinely recommended during active mumps outbreaks, even though there is no solid proof that this strategy is effective.
Considering two doses of the vaccine are failing to protect young adults from mumps, adding a third dose, plus two additional doses of measles and rubella vaccines, seems like a questionable strategy, especially in light of evidence that the mumps vaccine’s effectiveness may have been exaggerated to begin with.
WHAT NEVER MAKES MAINSTREAM MEDIA 'HEADLINES': VACCINE INJURY COURT
“As of March 1, 2018, there had been 1,060 claims filed in the federal Vaccine Injury Compensation Program for injuries and deaths following MMR or MMR-Varicella (MMRV) vaccinations …
Using the MedAlerts search engine, as of February 4, 2018, there had been 88,437 adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) in connection with MMR or MMRV vaccines since 1990.
Over half of those MMR and MMRV vaccine-related adverse events occurred in babies and young children 6 years old and under. Of the MMR and MMRV vaccine related adverse events reported to VAERS, 403 were deaths, with over 60 percent of the deaths occurring in children under 3 years of age.”
In 2010, two former Merck employees sued the company, alleging Merck artificially inflated the efficacy of the mumps portion of its MMR II vaccine in testing. To this day, 2019, the case is still pending
FDA documents obtained via FOIA requests filed by the Informed Consent Action Network reveal the MMR II vaccine was licensed based on clinical trials involving just 834 children, of which only 342 received the MMR vaccine; results show a shocking amount of vaccine reactions.
The eight licensing studies followed up on reactions for a mere 42 days’ post-vaccination, not years, as is done in drug testing. All trials also used other vaccines as controls rather than a placebo, which is not going to give you a valid indication of the vaccine’s safety profile.
All eight licensing trials reveal high ratios of gastrointestinal illness and upper respiratory illness occurring within the 42-day follow-up period. In one, 64 of 102 children (62.7%) in the MMR treatment group developed upper respiratory illness and 43 (42%) developed gastrointestinal illness.
OTHER VACCINE FAILURES
An Outbreak of Chickenpox in Elementary School Children with Two-Dose Varicella Vaccine Recipients (2006).
Ninety-seven percent of the children had been vaccinated for Varicella.
In this outbreak, 84 cases were reported.
In June 2006, a second dose of the chickenpox (varicella) vaccine was recommended for school entry. Shortly after school had begun, the Arkansas Department of Health was notified of a varicella outbreak in students.
--Pertussis Infection in Fully Vaccinated Children in Day Care Centers (2000)
Many health professionals are adamant that vaccines protect against infection. Evidence from a field investigation in Israel challenges this belief.
In 2000, a child died suspected of having pertussis. The baby received the first dose of DTP at two months of age – all family members were completely vaccinated with four doses of DTP.
The day care centers that two siblings had attended during the child’s illness were investigated. All the children in the day care had been vaccinated in infancy with four doses of diphtheria-tetanus toxoid pertussis (DTP) vaccine, and a booster dose at 12 months of age.
Five fully vaccinated children were found to be colonized with Bordetella pertussis.
At the conclusion of the investigation, researchers stressed the following information:
“Vaccinated adolescents and adults may serve as reservoirs for silent infection and become potential transmitters to unprotected infants. The whole-cell vaccine for pertussis is protective only against clinical disease, not against infection. Therefore, even young, recently vaccinated children may serve as reservoirs and potential transmitters of infection.”
They re-emphasized again, “Our results indicate that children ages 5-6 years and possibly younger, ages 2-3 years, play a role as silent reservoirs in the transmission of pertussis in the community.”
Vaccine coverage in daycare: 100%
-- Major Measles Epidemic in Quebec Despite 99% Vaccine Coverage (1989)
The 1989 measles outbreak infecting 1,363 people in the province of Quebec was INITIALLY explained away as occurring because of “incomplete vaccination coverage.”
However, upon further investigation, it was discovered the vaccination coverage among the total population was 99.0%.
-- Measles Outbreak in a Fully Immunized Secondary-School Population (1985)
In 1985, an outbreak of measles occurred in a secondary school located in Corpus Christi, Texas. More than 99% had records of vaccination with live measles vaccine. The investigators concluded “that outbreaks of measles can occur in secondary schools, even when more than 99 percent of the students have been vaccinated and more than 95 percent are immune.”
Vaccine coverage for school: 99%.
Less well-publicized is that a portion of measles reported in recently vaccinated persons may in fact be vaccine strain measles, an MMR vaccine side effect that is often misdiagnosed as wild type measles.
According to a paper published in the Journal of Clinical Microbiology in 2017:
“During the measles outbreak in California in 2015, a large number of suspected cases occurred in recent vaccinees. Of the 194 measles virus sequences obtained in the United States in 2015, 73 were identified as vaccine sequences.”
In other words, about 38 percent of suspected measles cases in the 2015 Disneyland measles scare in California were actually vaccine strain measles cases in recently vaccinated persons and not caused by transmission of wild-type measles. A reasonable question then would be: How many of the 704 cases reported in the U.S. so far this year are actually vaccine strain measles, a side effect of MMR vaccine?
Primary vaccine failure to routine vaccines: Why and what to do?
"There are 2 major factors responsible for vaccine failures, the first is vaccine-related such as failures in vaccine attenuation, vaccination regimes or administration.
The other is host-related, of which host genetics, immune status, age, health or nutritional status can be associated with primary or secondary vaccine failures. The first describes the inability to respond to primary vaccination, the latter is characterized by a loss of protection after initial effectiveness.
The question of whether non-responsiveness is an antigen-specific event or may occur in the same individual to several vaccine antigens was of further interest to be investigated."
Profits always soar amid "outbreak" hysteria and it IS about PROFITS, isn't it?
THEIR VACCINES FAIL.
THEIR EMPLOYEES SUE THEM.
WHY DOESN'T THE VACCINE INDUSTRY/BIG PHARMA SPEND THOSE HUGE PROFITS TO FINALLY RESEARCH AND DEVELOP VACCINES THAT DO WORK, AND WORK WITHOUT HARM OR FATALITIES?
//WW
No comments:
Post a Comment